Cart
sales@molnova.com
NSC639829
CAS No. 134742-19-1
NSC639829( NSC-639829 | NSC 639829 )
Catalog No. M11410 CAS No. 134742-19-1
A potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | 2325 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSC639829
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines.
-
DescriptionA potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines as well as in vivo against several tumor models, effectively inhibits in vitro tubulin polymerization.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC-639829 | NSC 639829
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
RecptorMicrotubule/Tubulin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number134742-19-1
-
Formula Weight470.327
-
Molecular FormulaC21H20BrN5O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC(NC1=CC=C(OC2=NC=C(Br)C=N2)C(C)=C1)=O)C3=CC=CC=C3N(C)C
-
Chemical NameN-((4-((5-bromopyrimidin-2-yl)oxy)-3-methylphenyl)carbamoyl)-2-(dimethylamino)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Abdel-Aziz W, et al. Invest New Drugs. 2003 Nov;21(4):421-8.
2. Jain A, et al. AAPS PharmSciTech. 2003 Oct 15;4(4):E52.
3. Balcer-Kubiczek EK, et al. Cancer Chemother Pharmacol. 2007 May;59(6):781-7.
4. Hallur G, et al. J Med Chem. 2006 Apr 6;49(7):2357-60.
molnova catalog
related products
-
Lexibulin dihydrochl...
An orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo.
-
Taccalonolide B
Taccalonolide B is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug-resistance protein (MRP7).?Taccalonolide B inhibits growth of SK-OV-3 cells with an IC50 of 208 nM.The structures were elucidated using a combination of spectroscopic methods, including 1D and 2D NMR and HR-ESI-MS.
-
Ombrabulin
A novel combretastatin A-4 derivative and tubulin polymerization inhibitor that strongly stanches tumour blood flows and inhibits growth of tumours developing in various tissues and organ.
